Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods - PubMed (original) (raw)

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods

Chun Chieh Chen et al. J Vis Exp. 2018.

Abstract

Virus-like particles (VLPs) have been used as nanocarriers to display foreign epitopes and/or deliver small molecules in the detection and treatment of various diseases. This application relies on genetic modification, self-assembly, and cysteine conjugation to fulfill the tumor-targeting application of recombinant VLPs. Compared with genetic modification alone, chemical conjugation of foreign peptides to VLPs offers a significant advantage because it allows a variety of entities, such as synthetic peptides or oligosaccharides, to be conjugated to the surface of VLPs in a modulated and flexible manner without alteration of the VLP assembly. Here, we demonstrate how to use the hepatitis E virus nanoparticle (HEVNP), a modularized theranostic capsule, as a multifunctional delivery carrier. Functions of HEVNPs include tissue-targeting, imaging, and therapeutic delivery. Based on the well-established structural research of HEVNP, the structurally independent and surface-exposed residues were selected for cysteine replacement as conjugation sites for maleimide-linked chemical groups via thiol-selective linkages. One particular cysteine-modified HEVNP (a Cys replacement of the asparagine at 573 aa (HEVNP-573C)) was conjugated to a breast cancer cell-specific ligand, LXY30 and labeled with near-infrared (NIR) fluorescence dye (Cy5.5), rendering the tumor-targeted HEVNPs as effective diagnostic capsules (LXY30-HEVNP-Cy5.5). Similar engineering strategies can be employed with other macromolecular complexes with well-known atomic structures to explore potential applications in theranostic delivery.

PubMed Disclaimer

Figures

References

    1. Ludwig C, Wagner R. Virus-like particles-universal molecular toolboxes. Curr Opin Biotechnol. 2007;18(6):537–545. -PMC -PubMed
    1. Galaway FA, Stockley PG. MS2 viruslike particles: a robust, semisynthetic targeted drug delivery platform. Mol Pharm. 2013;10(1):59–68. -PubMed
    1. Ma Y, Nolte RJ, Cornelissen JJ. Virus-based nanocarriers for drug delivery. Adv Drug Deliv Rev. 2012;64(9):811–825. -PubMed
    1. Chen CC, et al. Chemically activatable viral capsid functionalized for cancer targeting. Nanomedicine (Lond) 2016;11(4):377–390. -PMC -PubMed
    1. Jariyapong P, et al. Chimeric hepatitis E virus-like particle as a carrier for oral-delivery. Vaccine. 2013;31(2):417–424. -PMC -PubMed

Publication types

MeSH terms

LinkOut - more resources